Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PTGX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
PTGX
Protagonist Therapeutics, Inc
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
PTGX
Protagonist Therapeutics, Inc
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PTGX, solid
LLY, dashed
PTGX
Protagonist Therapeutics, Inc
Change
142.46
▼
−1.65%
Mkt cap
$9.4B
Revenue
$213M
Q2 FY26
Revenue
$46M
FY25
LLY
ELI Lilly & Co
Change
1,407.83
▼
−0.68%
Regular session
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
PTGX
Protagonist Therapeutics, Inc
vs
LLY
ELI Lilly & Co
142.46
▼
−1.65%
Price
1,407.83
▼
−0.68%
$9.4B
Mkt cap
$1.3T
Q2 FY26
$213M
Revenue
$24.4B
Q3 FY26
FY25
$46M
Revenue
$65.2B
FY25
Change
Change
PTGX
142.46
▼
−1.65%
vs
LLY
1,407.83
▼
−0.68%
Regular session